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Abstract
Background: Autologous blood transfusion drainage (ABTD) has been used for many years to reduce blood loss in
total knee arthroplasty (TKA). We evaluate the current evidence concerning the efficiency and safety of ABTD used
in TKA compared with conventional suction drainage (CSD).
Methods: We performed a systematic literature search of the PubMed, Embase, Cochrane Library and four Chinese
databases. All randomized controlled trials (RCTs) that compared the effects of ABTD versus CSD in TKA were
included in the meta-analysis.
Results: Sixteen RCTs involving 1534 patients who compared the effects of ABTD versus CSD were included. Five of
the RCTs were performed in Asia, ten in Europe, and one in North America. Patients in the ABTD group had a lower
blood transfusion rate (OR: 0.25 [0.13, 0.47]; Z = 4.27, P < 0.0001) and fewer units transfused per patient (WMD: −0.68
[−0.98, −0.39]; Z = 4. 52, P < 0.00001) than did patients in the CSD group. Wound complications, deep vein
thrombosis, febrile complications, post-operative hemoglobin days 5–8, drainage volume, and length of hospital
stay did not differ significantly between the two types of drainage systems.
Conclusion: This meta-analysis suggests that ABTD is a safe and effective method that yields a lower blood
transfusion rate and fewer units transfused per patient in TKA compared with CSD.
Keywords: Autologous blood transfusion drainage, Total knee arthroplasty, Meta-analysis, Randomized controlled trials
Background
Total knee arthroplasty (TKA) can result in significant
blood loss [1, 2]. One study estimated the average blood
loos in TKA to be 1500 mL [3]. The average reduction
in Hb concentration after TKA has been estimated to be
3.85 g/dL [4]. Blood transfusion may be considered
necessary in some patients to avoid symptomatic anemia
and subsequent delays in postoperative rehabilitation [5].
The blood transfusion rate in TKA reach 39 % [2, 6, 7].
Conventional suction drainage (CSD) is used world-
wide for postoperative wound blood collection in TKA
[8]. Formerly, CSD was believed to be effective in
decreasing hematoma formation [9–11] and potentially
able to decrease postoperative pain, swelling, and the in-
cidence of infection [12]. However, a closed suction
drainage system increases bleeding because it eliminates
the tamponade effect of a closed, undrained wound [8].
Surgeons use adjunctive measures such as autologous
blood transfusion drainage (ABTD) to reduce excessive
blood loss from the drain [13], and recent studies have
shown that ABTD can decrease the rate of blood
transfusion [14–16].
The efficacy and safety of ABTD in the management
of a patient’s blood during TKA surgery was assessed in
a previous meta-analysis of eight randomized controlled
trials (RCTs) [17]. The meta-analysis showed that ABTD
was superior to CSD with respect to the blood
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transfusion rate (OR: 0.25 [0.13, 0.47]; P < 0.0001), the
number of units transfused per patient (WMD: −0.84
[−1.13, −0.56]; P < 0.0001), and the length of hospital
stay (WMD: −0.25 [−0.48, −0.01]; P = 0.04). However,
data extraction errors involving the number of patients
requiring homologous blood transfusion occurred with
two of the studies [18, 19] included in the meta-analysis.
Furthermore, the meta-analysis did not employ intention-
to-treat (ITT) analysis, which may have led to anti-
conservative estimates of treatment effectiveness. In
addition, systematic reviews that fail to search non-
English databases may miss relevant studies and cause se-
lection bias [20]. As trials with statistically significant
results are more likely to be published in English than are
those with non-significant results [21], systematic reviews
that include studies published only in English might
overestimate true effects, In addition, the previous meta-
analysis did not evaluate the outcomes of additional
measures such as wound complications (including wound
infection, wound abscess, wound dehiscence, and wound
hematoma) and febrile complications.
In recent years, several studies comparing ABTD and
CSD have reported conflicting outcomes [1, 22–24].
Whether the benefits of ABTD are limited to the reduc-
tion of the blood transfusion rate is unclear. Therefore,
we comprehensively searched several bibliographic
databases to identify RCTs conducted to date. We then
analyzed the clinical evidence to evaluate the effective-
ness and safety of ABTD relative to CSD. We also inves-
tigated the potential benefits of ABTD.
Methods
In accordance with Preferred Reporting Items for System-
atic Reviews and Meta-analysis [25], we made a prospect-
ive protocol of objectives, literature-search strategies,
inclusion and exclusion criteria, outcome measurements,
and methods of statistical analysis before the research
began.
Data sources and search strategies
A systematic literature search of the Pubmed (1950–
February 2016), Embase (1974–February 2016), Cochrane
Library (February 2016 Issue 2), Chinese Biomedical Lit-
erature (CBM) (1990 to February 2016), China National
Knowledge Infrastructure (CNKI) (1979 to February
2016), Chinese Scientific Journals (VIP) (1989 to February
2016) and Wanfang (1982 to February 2016) databases
was conducted. The following MeSH terms or Emtree
terms and their combinations were searched in [Title/
Abstract]: “Drainage”, “Suction”, “Blood Transfusion,
Autologous”, “Operative Blood Salvage”, “Arthroplasty,
Replacement, Knee” or “wound drainage”, “closed
Fig. 1 Flow diagram of studies identified, included, and excluded
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drainage”, “drainage catheter”, “drainage tube”, “suction
drain”, “surgical drainage”, “drain”, “wound drain”, “blood
autotransfusion”, “autotransfusion unit”, “blood salvage”,
“knee arthroplasty”. (See Additional file 1 for details on
the search strategies.) Only articles that were originally
written in English or Chinese or that had been translated
into English were considered. Unpublished trials were not
included. When multiple reports describing the same
population were published, the most recent or complete
report was used. Additional eligible studies were sought
by searching the reference lists of primary articles and
relevant reviews.
Inclusion criteria
All available RCTs that compared ABTD with CSD in
TKA and for which one or more comparable quantita-
tive outcomes (the quantitative data must be presented
as means and standard deviations or 95 % confidence in-
tervals) could be extracted and analyzed were included.
Table 1 Characteristics of the included studies
Study Country Jadad score Patients, no. Surgical
method
Agea M:F ratio Pre-op Hba
ABTD CSD ABTD CSD ABTD CSD ABTD CSD
Deng YJ 2015 [40] China 1 11 12 B-TKA 57.7 ± 16.3 60.7 ± 17.3 5:6 5:7 13.4 ± 3.6 13.5 ± 3.7
Jin CH 2014 [42] China 1 70 70 SU-TKA 66 ± 4 64 ± 4 12:58 13:57 13.1 ± 1.3 13. 2 ± 1. 4
Sun YT 2014 [39] China 1 72 60 SU-TKA 65.3 64.7 15:57 13:47 13.1 ± 1.4 13.4 ± 2.0
Amin A 2008 [29] UK 2 92 86 SU-TKA 70.3 70.4 43:49 39:47 13.2 ± 1.2 13.4 ± 1.3
Shen Y 2007 [41] China 0 60 60 SU-TKA NA NA NA NA NA NA
Zacharopoulos A
2007 [30]
Greece 1 30 30 SU-TKA 69.2 70.2 6:24 7:23 NA NA
Abuzakuk T 2007 [31] UK 2 52 52 SU-TKA NA NA 21:31 22:30 13.6 ± 1.5 13.5 ± 1.2
Kirkos JM 2006 [32] Greece 0 78 77 SU-TKA 69.1 ± 5.5 68.9 ± 5.1 18:60 10:67 13.0 ± 1.4 13.1 ± 1.4
Dramis A 2006 [33] UK 1 25 24 SU-TKA NA NA NA NA NA NA
Cheng SC 2005 [34] China 2 26 34 SU-TKA 72 69.6 6:20 12:22 12.4 12.8
Thomas D 2001 [35] UK 2 115 116 SU-TKA NA NA 44:71 55:61 NA NA
Breakwell LM 2000 [36] UK 1 14 19 B-TKA 66.8 73.7 8:6 8:11 12.9 12.8
Adalberth G 1998 [18] Sweden 3 30 30 SU-TKA 71 ± 5.4 72 ± 8.0 NA NA 13.8 ± 1.1 14.3 ± 1.3
Newman J 1997 [37] UK 2 35 35 SU-TKA NA NA NA NA 13.4 ± 1.2 13.2 ± 1.4
Heddle NM 1992 [19] Canada 3 39 40 SU-TKA 69.3 ± 6.9 71.0 ± 9.0 25:14 26:14 NA NA
Majkowski RS 1991 [38] UK 1 20 20 SU-TKA 71.3 70.3 6:14 6:14 13.2 12.7
SU-TKA selective unilateral total knee replacement, B-TKA bilateral total knee replacement, ABTD autologous blood transfusion drainage, CSD conventional suction
drain, NA data not available, M male, F female, Pre-op Hb pre-operative hemoglobin
aMean or Mean ± SD
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
Fig. 2 Risk of bias summary
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Exclusion criteria
We excluded case reports, non-original research (e.g.,
review articles, editorials, letters to the editor), non-
human animal studies, and duplicate publications.
Data extraction and analysis
Data abstraction was conducted by two authors (Hong
and Xie) independently. In cases of disagreement,
consensus was established through discussion with two
other experienced authors (Pan and J. Liu).
The primary outcomes were blood transfusion rate,
mean number of units transfused per patient, wound
complications, and deep vein thrombosis.
The secondary outcomes were febrile complications,
post-operative hemoglobin on days 5–8, drainage
volume, and length of hospital stay.
Quality assessment
The Jadad quality scale [26] and the Cochrane risk of
bias tool [27] were used to assess the methodological
quality of the included RCTs. Studies with a Jadad
score ≥ 3 were considered high quality, and those with a
Jadad score ≤2 were considered low quality.
Data synthesis and analysis
We based our analysis on intent-to-treat (ITT) or modi-
fied ITT data. Review Manager 5.3.5 (Cochrane) was
employed for the meta-analysis. Odds ratios (ORs) and
95 % confidence intervals (CIs) were calculated for blood
transfusion rate, wound complications, deep vein throm-
bosis and febrile complications. Weighted mean differ-
ences (WMDs) and 95 % CIs were calculated for the
mean number of units transfused per patient, post-
operative hemoglobin on days 5–8, drainage volume,
and length of hospital stay. We regarded the volume of
one unit of transfused blood as approximately 300 mL
[18, 28]. When continuous data from the included studies
were presented as means and 95 % confidence intervals,
standard deviations were calculated by using Review
Manager 5.3.5 (Cochrane).
Heterogeneity among the studies was assessed using
the I-square test. Where heterogeneity (I2 > 50 %) was
detected, a random-effects model was applied; otherwise,
a fixed-effects model was applied [27]. For outcome
measures with I2 values greater than 50 %, we conducted
sensitivity analyses to determine the source. Funnel plots




Sixteen [18, 19, 29–42] studies including 1534 cases
(769 cases for ABTD and 765 cases for CSD) met the in-
clusion criteria and were included in the final analysis
(Fig. 1). Search of the reference lists revealed no
additional studies that met the inclusion criteria.
Characteristics of the included studies
The characteristics of the included studies are summa-
rized in Table 1. Four studies [39–42] were identified
from Chinese databases, and 12 studies [18, 19, 29–38]
were identified from international databases. Geographically,
five RCTs were performed in Asia, 10 in Europe, and one in
North America.
Fig. 3 Risk of bias assessment
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We evaluated the methodological quality of all of the
included studies using the Jadad quality scale and
Cochrane risk of bias criteria (Table 1, Figs. 2 and 3).
The Jadad scores ranged from 0 to 3 points, with an
average score of 1.4. Only two RCTs [18, 19] were of
high quality. Six studies [18, 19, 29, 31, 34, 37] reported
a method of randomization, and two studies [32, 41]
used a method of quasi-randomization. The remaining
eight studies [30, 33, 35, 36, 38–40, 42] did not report
the method of randomization. None of the included
studies used the double-blinded method. The two RCTs
[18, 19] of high quality described the number of cases and
the reasons for drop-out in detail. Two studies [18, 34]
reported the method of allocation concealment. One
study [34] provided information regarding the blind-
ing method. None of the 16 studies [18, 19, 29–42]
reported the method of blinding outcome assessment.
Fifteen studies [18, 19, 29–35, 37–42] reported the
complete analysis. One study [37] was at high risk of
selective reporting.
Patients in 14 studies [18, 19, 29–35, 37–39, 41, 42]
were undergoing selective unilateral TKA, and those
of the remaining two [36, 40] were undergoing bilat-
eral TKA.
The majority of the RCTs reviewed in this meta-
analysis were of low quality. All of the included studies
reported that the baseline characteristics of the study
groups, including age, gender and pre-operative
hemoglobin, were comparable, as shown in Table 1.
Primary outcomes
Blood transfusion rate
Twelve trials [18, 19, 29–31, 33–35, 37–39, 42] com-
pared ABTD with CSD in the number of patients requir-
ing homologous blood transfusion. Ten trials [18, 19,
29–31, 33–35, 37–39, 42] showed substantial heterogen-
eity in the trial results (chi-square = 48.42, P < 0.00001;
I2 = 77 %). Therefore, a random effects model was used
for statistical analysis. The meta-analysis showed a sig-
nificant beneficial effect of ABTD compared with CSD
on blood transfusion rate (16.50 and 40.54 %, respect-
ively; OR: 0.25 [0.13, 0.47]; Z = 4.27, P < 0.0001) (Fig. 4).
Due to marked heterogeneity in the blood transfusion
rate data, sensitivity analysis was conducted by excluding
Fig. 4 Blood transfusion rate
Fig. 5 Mean number of units transfused per patient
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one study randomly. Dropping any one study did not
reduce the heterogeneity, suggesting that the result was
robust against the heterogeneity.
Mean number of units transfused per patient
Five trials [18, 19, 32, 40, 41] that included a total of 437
patients reported the mean number of units transfused
per patient (Fig. 5). These five trials [18, 19, 32, 40, 41]
showed moderate heterogeneity in the results (chi-
square = 15.14, P = 0.004; I2 = 74 %). Therefore, a random
effects model was used for statistical analysis. The meta-
analysis showed a significant beneficial effect of ABTD
compared with CSD; i.e., a lower mean number of units
transfused per patient (WMD: −0.68 [−0.98, −0.39];
Z = 4.52, P < 0.00001). Due to marked heterogeneity
in blood transfusion rate, sensitivity analysis was con-
ducted by excluding one study [40] of lower quality, which
reduced the heterogeneity (I2 = 12 %, P = 0.33). The ran-
dom effects model also showed a significant beneficial
effect of ABTD relative to CSD (WMD: −0.56 [−0.68,
−0.44]; Z = 9.39, P < 0.00001). Dropping any one study did
not influence the qualitative result.
Wound complications
The analysis of data extracted from three studies [29, 35,
38] that assessed wound complications in 449 patients
revealed no significant difference between the ABTD
and CSD groups (4.85 and 4.95 %, OR: 0.98 [0.40, 2.38];
Z = 0.04, P = 0.97). No significant heterogeneity was
detected (P = 0.66, I2 = 0 %) (Fig. 6).
Deep vein thrombosis
Data extracted from four studies [18, 29, 35, 38] that
assessed deep vein thrombosis in 509 patients showed
no significant difference between the ABTD and CSD
groups (1.56 and 2.38 %, OR: 0.69 [0.21, 2.24]; Z = 0.61,
P = 0.54). No significant heterogeneity was detected
(P = 0.64, I2 = 0 %) (Fig. 7).
Secondary outcomes
Febrile complications
Six trials [19, 31, 32, 34, 36, 37] compared ABTD with
CSD with respect to febrile complications. These six
trials showed substantial heterogeneity in the results
(chi-square = 11.28, P = 0.05; I2 = 56 %); therefore, a ran-
dom effects model was used. The meta-analysis showed
no significant difference between the two groups (20.49
and 25.68 %, OR: 0.78 [0.25, 2.40]; Z = 0.43, P = 0.67)
(Fig. 8). Due to marked heterogeneity in the febrile com-
plications data, sensitivity analysis was conducted by
excluding one study [37] of lower quality, which reduced
the heterogeneity (I2 = 30 %, P = 0.22). The random
effects model also showed no significant difference
between the ABTD and CSD groups (21.01 and 22.52 %,
OR: 1.21 [0.39, 3.68]; Z = 0.33, P = 0.74). Dropping any
one study did not qualitatively alter the result.
Post-operative hemoglobin on days 5–8
Four studies [18, 31, 37, 42] reported post-operative
hemoglobin on days 5–8. Among these studies, one [31]
Fig. 6 Wound complication
Fig. 7 Deep vein thrombosis
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reported hemoglobin on the fifth day post-operation,
one [18] reported hemoglobin on the eighth day post-
operation, and the remaining two [37, 42] reported
hemoglobin on the seventh day post-operation. Because
the four studies [18, 31, 37, 42] showed moderate hetero-
geneity in the results (chi-square = 5.74, P = 0.13; I2 = 48 %),
a fixed effects model was used. The meta-analysis showed a
significant beneficial effect of CSD compared with ABTD
on post-operative hemoglobin on days 5–8 (WMD: 0.21
[−0.07, 0.48]; Z = 1.47, P = 0.14) (Fig. 9).
Drainage volume
Seven studies [18, 19, 31, 37–39, 41] reported post-
operative drainage volume. These seven studies showed
moderate heterogeneity in the results (chi-square = 9.03,
P = 0.17; I2 = 34 %); therefore, a fixed effects model was
used. Pooling and analysis of the data of the 605 patients
from the seven studies revealed no significant difference
between the ABTD and CSD groups (WMD: −2.91
[−43.50, 37.68]; Z =0.14, P = 0.89) (Fig. 10).
Length of hospital stay
Three trials [18, 31, 37] compared ABTD with CSD in
length of hospital stay. The three trials [18, 31, 37] showed
substantial heterogeneity in the results (chi-square = 4.14,
P = 0.13; I2 = 52 %); therefore, a random effects model was
used. The meta-analysis showed no significant difference
in length of hospital stay between the ABTD and CSD
groups (WMD: −0.96 [−2.09, 0.17]; Z = 1.67, P = 0.10)
(Fig. 11). Due to marked heterogeneity in length of
hospital stay, sensitivity analysis was conducted by exclud-
ing one study [37] of lower quality, resulting in no signifi-
cant heterogeneity detected (P = 0.32, I2 = 0 %). The
random effects model also showed no significant differ-
ence between the two groups in length of hospital stay
(WMD: −0.52 [−1.30, 0.25]; Z = 1.33, P = 0.18).
Publication bias
The funnel plot of blood transfusion rate (Fig. 12) showed
a markedly asymmetrical distribution of effect estimate,
which indicated the presence of publication bias.
Discussion
The meta-analysis of 16 RCTs, including 1534 patients,
suggested that ABTD is a safe system that yields a sig-
nificantly reduced blood transfusion rate and fewer units
of transfused blood per patient compared with CSD. We
found no significant differences between the two drainage
systems in wound complications, deep vein thrombosis,
febrile complications, post-operative hemoglobin on days
5–8, drainage volume, or length of hospital stay.
TKA patients require post-operative allogenic blood
transfusion, which was markedly reduced by using
ABTD compared with CSD. Although allogenic transfu-
sion remains the most popular method of compensating
for blood loss in TKA patients, it can have potential
deleterious effects, including transfusion-related in-
fection, incompatibility-related transfusion reaction,
Fig. 8 Febrile complications
Fig. 9 Post-operative haemoglobin days 5–8
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immune modulatory effects, and febrile complica-
tions [34]. These risks have led to use of autologous
pre-donation blood, which also has drawbacks, e.g.,
difficulty of organizing patients for pre-donation and
adherence to iron or erythropoietin therapy [43].
Studies have reported that nearly half of the autolo-
gous blood donated by patients for surgery is dis-
carded [44, 45]. The use of autologous pre-donation
blood is wasteful and costly [46]. Compared with the
use of autologous pre-donation blood, ABTD has
been found to be easier to perform, more cost-
effective and able to lower the risks associated with
allogenic blood use [47]. The present meta-analysis
found that ABTD showed a significantly reduced
blood transfusion rate and number of units trans-
fused per patient; therefore, although the ABTD de-
vice is more expensive than CSD, a TKA patient
using ABTD could spend 20 to 70 % less money on
allogenic blood transfusion [30, 32, 34–36]. The pro-
cedures for setting up an ABTD system are similar
to those for standard allogeneic blood transfusions
[34] and require no additional medical personnel,
but they do add staff time [31, 35]. The exact costs
saved by using ABTD was not quantified in the
present study because the unit cost of allogenic
blood varies among regions.
Analysis of the extracted data on postoperative out-
comes demonstrated that ABTD is safe and effective for
TKA. There were no significant differences between
ABTD and CSD in wound complications, deep vein
thrombosis, and febrile complications. Kristiansson et al.
[48] found that hypercoagulability and high concentra-
tions of IL-6 were present in drained blood. Some stud-
ies have reported that drained blood shows decreased
platelet counts, pH levels, and clotting factor levels as
well as increased fibrin degradation products [49, 50].
Hand et al. [51] identified low levels of methyl meth-
acrylate monomers in filtered blood. Contra-indications
to the use of unwashed shed blood have been formulated
by the American Association of Blood Banks [52], who
suggested that various cytokines are activated in drained
blood and may be problematic for some patients if they
increased to higher levels more than 6 h after bleeding
[53]. In all of the studies included in the present meta-
analysis, re-infusion was completed within 6 h post-
operation. A lower rate of allogenic blood transfusion
may help prevent febrile complications. Postoperative
febrile complications were generally observed in the
context of major orthopedic surgery, and it has been
suggested that the rise in temperature is a response to
the surgical procedure [54]. Some previous studies have
also reported no difference between ABTD and CSD in
the development febrile complications [55–57]. The ab-
sence of significant differences in wound complications,
deep vein thrombosis, and febrile complications between
ABTD and CSD indicate that ABTD is as safe as CSD.
Analysis of the pooled data revealed no significant dif-
ference in drainage volume, suggesting that ABTD is
equally safe as CSD with respect to wound bleeding.
We found no significant differences between the two
systems in post-operative hemoglobin on days 5–8.
ABTD was found to be effective in reducing allogeneic
Fig. 10 Drainage volume
Fig. 11 Length of hospital stay
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blood transfusions but not in achieving high postopera-
tive hemoglobin levels. A high postoperative hemoglobin
level has been reported to be associated with better re-
habilitation outcomes after TKA [58]. The present find-
ings suggest that ABTD was not useful in achieving high
postoperative hemoglobin levels to enhance rehabilita-
tion, similar to the findings of other studies [57, 59].
The present meta-analysis revealed no significant dif-
ference in length of hospital stay between ABTD and
CSD. However, the previous meta-analysis [17] found a
longer length of hospital stay in the CSD group. The
data on length of hospital stay in Amin A et al. [29] were
presented as means and ranges, and we were unable to
obtain the original data by contacting the corresponding
author. Therefore, we excluded these data [29], which
were included in the previous meta-analysis [17]. Due to
country and regional variation in medical insurance pol-
icies and social support facilitating discharge, the length
of hospital stay could not be used in the present study
as a measure of cost [36].
Two studies [36, 40] on bilateral TKA reported differ-
ent outcomes that could not be synthesized. Due to this
limited number of studies and insufficient description of
the study methods, the outcomes could not be analyzed
in a subgroup analysis.
To assess the impact of one study on the effect esti-
mates, we performed sensitivity analysis by excluding
one study with a high weight or of lower quality. The
results regarding blood transfusion rate, febrile compli-
cations, and length of hospital stay were qualitatively
unchanged by this analysis. However, as a result of the
sensitivity analysis, the original result regarding post-
operative hemoglobin on days 5–8 was changed to favor
CSD, and the heterogeneity decreased from 48 to 0 %
when the study by Adalberth et al. [18] was excluded.
Analysis of the four studies [18, 31, 37, 42] reporting on
pre-operative hemoglobin revealed no significant difference
between the two systems (Heterogeneity: chi-square = 3.09,
P = 0.38; I2 = 3 %; WMD: −0.07 [−0.33, 0.20]; Z = 0.49, P =
0.62). Some non-RCT studies [43, 60] have similarly found
no significant difference in hemoglobin levels before and
after TKA between the ABTD and CSD groups. Another
study [31] found that ABTD could prevent a rapid
decrease in hemoglobin level during the early post-
operative period, although this benefit was no longer
present by post-operative day 5. Because only three
studies [18, 31, 37] included in this meta-analysis re-
ported on post-operative hemoglobin, further studies
are needed to evaluate the benefit of ABTD with re-
spect to post-operative hemoglobin.
Limitations
This meta-analysis has limitations. We used the Jadad
quality scale [26] and the Cochrane risk of bias tool [27]
to assess the methodological quality of the included
RCTs. According to the Jadad quality scale, the average
score of the included studies was 1.4, and only two RCTs
[18, 19] were of high quality. The Jadad score places
more emphasis on reporting rather than performance,
and its advantage is its simplicity and easy implementation.
Fig. 12 Funnel plot of blood transfusion rate
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The Jadad score was used in this study because it makes it
easy for readers to comprehend the quality of the included
studies. Although a lack of adequate allocation concealment
have been found in Jadad scores, this domain was assessed
using criteria adopted from the Cochrane Handbook. The
more important evaluation method used in this study is the
Cochrane risk of bias tool.
The majority of the included RCTs were of moderate
quality, and their sample sizes were comparatively small.
In addition, it appears that the lack of random sequence
generation increased the risk of bias.
Another limitation is that adequate information concern-
ing each final outcome was not consistently provided
among the 16 studies included. Furthermore, a prerequisite
for the initial meta-analysis was the assumption of similarity
between the two kinds of surgeries (SU-TKA and B-TKA),
which enabled them to be evaluated together.
Fortunately, the results of the sensitivity analyses were
similar to those of the original analyses. Another limita-
tion of the present study is the heterogeneity among the
included studies, which may reflect inter-study differences
in analysis methodology, surgical method (SU-TKA vs. B-
TKA), country and racial type. Future systematic reviews
should assess different surgical methods, countries and
racial types individually when sufficient high-quality RCT
data become available. Surgeon experience in various
TKA surgical approaches might also influence the results.
Finally, as few of the included studies involving long-term
follow-up, long-term outcomes could not be evaluated
and require further study.
Conclusions
The present meta-analysis indicated that ABTD is more
efficacious than CSD in reducing the blood transfusion rate
and the number of units transfused per patient in TKA pa-
tients. The two types of drains appear to be equivalent in
terms of wound complications, deep vein thrombosis,
febrile complications, post-operative hemoglobin on days
5–8, drainage volume, and length of hospital stay. The
results of this meta-analysis can help TKA surgeons make
clinical decisions. The development of large-volume, well-
designed RCTs and clinical trials with extensive follow-up
will clarify the advantages and disadvantages of ABTD.
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